Pfizer Options Spot-On: On January 27th, 219.47K Contracts Were Traded, With 2.82 Million Open Interest
Wall Street Today: Nvidia and Chips Pull Back Hard, Market Falls, Dow Holds On
Pfizer Gains After Activist Investor Forgoes Board Nominations
Sector Update: Health Care
Pfizer's Conditionally Approved Braftovi Combo Therapy Regime Shows Improved Response In Colorectal Cancer Patients
Pfizer Shares Are Trading Higher. The Stock May Be Higher Amid Activist Starboard Value's Decision to Not Pursue a Proxy Battle With the Company.
Express News | Pfizer Shares Are Trading Higher. The Stock May Be Higher Amid Activist Starboard Value's Decision to Not Pursue a Proxy Battle With the Company
Market Chatter: Pfizer Seen Getting Respite From Battle With Activist Investor Starboard
10 Health Care Stocks With Whale Alerts In Today's Session
Intellia Downgraded at Morgan Stanley on Lowered Expectations for Rare Disease Asset
Starboard Did Not Nominate Pfizer Board Members, Bloomberg Says
Live Stock: NVIDIA Falling 15%, If It only Takes ~$6M for a Singularity, Why is the Market Paying Trillions
Lucia and Heart Rhythm Society Announce Strategic Collaboration to Enhance UpBeat.org for AFib Patients, Sponsored by the BMS-Pfizer Alliance
Express News | No Proxy Fight for Pfizer From Starboard- CNBC
Pfizer Reports Positive Outcomes From Trial of MCRC Combination Therapy
Pfizer to Pay $59.7 Million to Resolve Biohaven's Alleged Kickback Scheme for Nurtec ODT
Pfizer's BRAFTOVI Combination Gets FDA Approval, Improves Outcomes in Colorectal Cancer
Financial Crime Weekly: Pfizer Pays Nearly $60 Million To Resolve False Claims Allegations, SEC Creates Crypto Task Force
Pfizer Succeeds in Late-stage Trial for Colorectal Cancer Therapy
Express News | Pfizer’s Braftovi® Combination Regimen Demonstrates Improved Response in Patients With Braf V600E-Mutant Metastatic Colorectal Cancer